On June 20, 2017, Icagen, Inc. and Omdana Therapeutics, Inc. announced a collaboration to help advance the discovery of novel medicines for disorders related to tissue homeostasis and vascular remodeling such as pulmonary hypertension. Omdana, a company co-founded by pharma veterans Drs. Christopher VanDeusen and Steve Ledbetter, will partner with Icagen as an integrated drug discovery team with the goal of developing high-quality, advanced leads ready for clinical trials.
Category Archives: AZBio News
AZ Business to Feature Arizona’s Bioscience Industry in Sept/Oct Issue
The AZ Business September/October Issue will feature a special supplement on Arizona’s Bioscience Industry in preparation for Arizona Bioscience Week 2017. Click here to learn more about AZBW 2017.
Phoenix Health Tech Entrepreneurs Align to Address the Growing Demand for Digital Healthcare
Four Phoenix based health tech companies have formed an alliance to promote digital innovation in healthcare, strategically focusing on improving healthcare processes and providing connected care to patients outside of the care setting.Continue reading
Solving a sweet problem for renewable biofuels and chemicals
ASU scientists harness the trial-and-error power of evolution to coax nature into revealing answer to energy challengeContinue reading
Medical Hackers Beware – These Docs Are On The Case
College of Medicine – Phoenix Featured on ABC News Nightline Special – National news segment showcases alumni Christian Dameff, MD, Jeff Tully, MD, and the state-of-the-art Center for Simulation and Innovation.
$120 million Research Building Tops Out – Check out what is planned for Biodesign Institute C
Research building will house a key drug discovery and bioenergy research tool: The world’s first compact free-electron X-ray laserContinue reading
Happy Birthday TGen
On June 26, 2002, the state of Arizona embarked on an exciting effort to transform its economy and revolutionize healthcare when then-Governor Jane Hull announced the creation of the Translational Genomics Research Institute. Today, TGen celebrates how far we have come: Delivering earlier diagnoses and smarter treatments based on a patient’s DNA blueprint. Click on the infographic above to learn about some of our past achievements, and watch the videos below to see where we’re headed in our cancer and neurological research.Continue reading
Quest to Prevent Macular Degeneration Continues With UA Researcher’s $1.7M NIH Grant
After showing that individuals who take levodopa, or l-dopa, for movement disorders such as Parkinson’s disease are protected from developing macular degeneration, University of Arizona researcher Brian S. McKay, PhD, is taking the next step in his quest to prevent the blinding eye disease, thanks to a $1.7 million R01 grant from the National Eye Institute of the National Institutes of Health.
